ambit biosciences corp
(AMBI:Consolidated Issue listed on NASDAQ Global Market)
Mark Levis M.D., Ph.D.
Member of Hematology and Oncology Clinical Advisory Board, Ambit Biosciences Corporation
|Age||Total Calculated Compensation||This person is connected to 20 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Mark Levis, M.D., Ph.D. has been Member of the Hematology and Oncology Clinical Advisory Board of Ambit Biosciences Corporation since February 28, 2008. Mr. Levis serves as Assistant Professor at Johns Hopkins University in Baltimore. Mr. Levis laboratory research focuses on the development of molecularly targeted therapies for leukemia. Currently, he is actively involved in the pre-clinical and clinical development of small molecule inhibitors of the receptor tyrosine ...
11080 Roselle StreetPhone: 858-334-2100
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|